Synereca Pharmaceuticals is Drug Discovery in United States that focus on operator business. Founded in 2009. They cover business area such as operator, novel orally active drug, existing antibiotic, five chemical subclass, compound, current class, polymyxin, carbapenem, aminoglycoside, fluoroquinolone, drug manufacture company, effective medication, bacterial infection.
2009
( 15 years old in 2024 )
Operator
-
865 Research Parkway, Suite 400
PHF Research Park
Oklahoma City, OK 73104
United States
Private
operatornovel orally active drugexisting antibioticfive chemical subclasscompoundcurrent classpolymyxincarbapenemaminoglycosidefluoroquinolonedrug manufacture companyeffective medicationbacterial infection
* We use standard office opening hours in near Synereca Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Synereca Pharmaceuticals is Drug Discovery business from United States that founded in 2009 (15 years old in 2024), Synereca Pharmaceuticals business is focusing on Operator.
Synereca Pharmaceuticals headquarter office and corporate office address is located in 865 Research Parkway, Suite 400 PHF Research Park Oklahoma City, OK 73104 United States.
Synereca Pharmaceuticals was founded in United States.
In 2024, Synereca Pharmaceuticals is currently focus on operator sector.
Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Synereca Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
